MTND1P21

Across TCGA pan-cancer cohorts, MTND1P21 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MTND1P21 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MTND1P21 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND1P21 expression acts as an unfavorable survival marker, although some lineages such as CESC and COAD show a favorable association.

LUAD, LUSC, and ACC are the cancer types where MTND1P21 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.493	0.809	<.001	87	view →
LUSC	OS	Tertile	All	0.189	0.529	<.001	78	view →
ACC	OS	Tertile	All	0.133	0.686	.004	54	view →
UCEC	OS	Tertile	All	0.755	0.879	.007	54	view →
ESCA	OS	Tertile	IV	0.135	0.568	.031	36	view →
PAAD	OS	Tertile	II,III,IV	0.213	0.522	.031	18	view →
CHOL	DFS	Tertile	All	0.037	0.497	.004	18	view →
SARC	OS	Tertile	All	0.299	0.775	<.001	18	view →
CESC	OS	Tertile	II,III,IV	1.000	0.724	.030	12	view →
COAD	DFS	Tertile	All	1.000	0.671	.031	9	view →
READ	DFS	Tertile	IV	0.255	0.628	.020	9	view →
GBM	OS	Tertile	All	0.341	0.191	.004	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

MTND1P21–LUAD (OS)

Open the LUAD breakdown →